EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have been assigned an average recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have updated their coverage on […]
More Stories
City Office REIT, Inc. Announces Quarterly Dividend of $0.10 (NYSE:CIO)
City Office REIT, Inc. (NYSE:CIO – Get Free Report) announced a quarterly dividend on Monday, September 16th, Wall Street Journal...
Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) Declares Monthly Dividend of $0.09
Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB – Get Free Report) announced a monthly dividend on Monday, September 16th, Wall...
National Fuel Gas Plans Quarterly Dividend of $0.52 (NYSE:NFG)
National Fuel Gas (NYSE:NFG – Get Free Report) declared a quarterly dividend on Monday, September 16th, Wall Street Journal reports....
Energy Web Token (EWT) Trading 0.7% Higher This Week
Energy Web Token (EWT) traded down 2.6% against the US dollar during the 1 day period ending at 16:00 PM...
Xai Hits 24-Hour Trading Volume of $12.81 Million (XAI)
Xai (XAI) traded down 6.6% against the dollar during the twenty-four hour period ending at 16:00 PM E.T. on September...
DataHighway Price Reaches $0.0465 on Major Exchanges (DHX)
DataHighway (DHX) traded 5% lower against the dollar during the 1-day period ending at 16:00 PM ET on September 16th....